ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 34 filers reported holding ELEDON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,927,593 | 0.0% | 4,326,710 | 0.0% | 0.16% | -3.0% |
| Q2 2023 | $5,927,593 | +8.0% | 4,326,710 | +86.0% | 0.16% | -17.9% |
| Q1 2023 | $5,491,036 | +1.7% | 2,326,710 | 0.0% | 0.20% | -11.8% |
| Q4 2022 | $5,397,967 | -15.9% | 2,326,710 | 0.0% | 0.23% | -14.0% |
| Q3 2022 | $6,422,000 | +13.1% | 2,326,710 | 0.0% | 0.26% | -3.3% |
| Q2 2022 | $5,677,000 | -38.1% | 2,326,710 | 0.0% | 0.27% | -25.3% |
| Q1 2022 | $9,167,000 | +50.8% | 2,326,710 | +68.8% | 0.37% | +66.1% |
| Q4 2021 | $6,077,000 | -27.9% | 1,378,020 | +1.1% | 0.22% | -32.8% |
| Q3 2021 | $8,426,000 | -4.3% | 1,363,435 | +22.5% | 0.33% | -0.3% |
| Q2 2021 | $8,807,000 | -26.1% | 1,113,435 | 0.0% | 0.33% | -26.2% |
| Q1 2021 | $11,914,000 | – | 1,113,435 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 234,803 | $321,680 | 0.34% |
| BVF INC/IL | 4,326,710 | $5,927,593 | 0.16% |
| ARMISTICE CAPITAL, LLC | 1,824,000 | $2,498,880 | 0.04% |
| SVB FINANCIAL GROUP | 13,472 | $18,457 | 0.04% |
| JMAC ENTERPRISES LLC | 58,041 | $79,516 | 0.02% |
| Woodline Partners LP | 603,993 | $827,470 | 0.01% |
| INGALLS & SNYDER LLC | 51,849 | $71 | 0.00% |
| Ensign Peak Advisors, Inc | 443,001 | $606,911 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 27,150 | $37,196 | 0.00% |
| Curi RMB Capital, LLC | 10,000 | $13,700 | 0.00% |